Hostname: page-component-7c8c6479df-ph5wq Total loading time: 0 Render date: 2024-03-29T04:00:16.652Z Has data issue: false hasContentIssue false

A Controlled Trial with Trimipramine, a New Anti-Depressant Drug

Published online by Cambridge University Press:  29 January 2018

M. M. Salzmann*
Affiliation:
Park Prewett Hospital, Basingstoke, Hants

Extract

This paper describes a double blind controlled trial of the compound trimipramine ('Surmontil’), which does not appear hitherto to have been reported upon by the English-speaking investigators, though there have been many clinical studies reported by French, and some by Italian authors.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1965 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Julou, L., Leau, O., Ducrot, R., Fournel, J., and Bardone, M. G. (1961). “General pharmacological properties of 5-(3-dimethylamino-2-methyl-propyl)-iminodibenzyl (7162 R.P.) and its dextro (10633 R.P.) and laevo (10645 R.P.) optical isomers.” Compt. Rend. Soc. Biol. (Paris), 155, 2, 307–312.Google Scholar
Lambert, P. A., and Guyotat, J. (1961). “Therapeutic trials of a new anti-depressant derivative, 7162 R.P.—therapeutic trials.” Presse Méd., 69, 31, 1425–1428.Google Scholar
Lambert, P. A., and Guyotat, J. and Charriot, G. (1962). “New perspectives in psychopharmacology of depressive conditions.” Communication au Congrès Hellénique de Psychiatrie—Athènes, 112.Google Scholar
Siowald, J., Bouttier, D., Raverdy, Ph., Raymondeau, Cl., Perrier, P., and Donnet, J. L. (1961). “Psychoactive agent 7162 R.P. (Dimethyl-amino-3 methyl-2 propyl)-5 iminodibenzyl: therapeutic antipsychotic and analgesic properties.” Presse Mid., 69, 42, 1780–1783.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.